Status:
COMPLETED
GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer
Lead Sponsor:
Seoul National University Hospital
Conditions:
Infertility
Polycystic Ovary Syndrome
Eligibility:
FEMALE
20-40 years
Phase:
PHASE3
Brief Summary
GnRH (Gonadotropin-releasing hormone) antagonists in IVF (in vitro fertilization) has been accomplished by several randomized controlled trials compared with conventional GnRH agonist long protocol in...
Detailed Description
GnRH Antagonist is Started on Stimulation Day 1 GnRH Antagonist is Started on Stimulation Day 6 Conventional GnRH Agonist Long Protocol
Eligibility Criteria
Inclusion
- PCOS patients (diagnosed as 2003 ASRM(The American Society for Reproductive Medicine)/ESHRE(The European Society of Human Reproduction and Embryology) consensus meeting guideline)
- age 20-40 years
- patients who have normal uterus
- Korean ethnicity
Exclusion
- patients who have abnormal thyroid function
- patients who have abnormal prolactin test
- patients who have diabetes, or Cushing's syndrome, or congenital adrenal hyperplasia, or androgen-producing tumor.
- Patients who reject informed consent
- patients who have experience of adverse events for GnRH agonist, antagonist, recombinant FSH(follicle-stimulating hormone).
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2016
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT01402336
Start Date
June 1 2011
End Date
December 31 2016
Last Update
October 10 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea